We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.94B
AUM Growth
-$6.24M
Cap. Flow
-$8.36M
Cap. Flow %
-0.43%
Top 10 Hldgs %
18.4%
Holding
264
New
14
Increased
88
Reduced
101
Closed
15

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$20.5M
2
CELH icon
Celsius Holdings
CELH
+$20M
3
AHCO icon
AdaptHealth
AHCO
+$19.3M
4
NOG icon
Northern Oil and Gas
NOG
+$18.9M
5
PRVA icon
Privia Health
PRVA
+$16.5M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$24.9M
2
AVNT icon
Avient
AVNT
+$21.7M
3
ONTO icon
Onto Innovation
ONTO
+$20M
4
ALKS icon
Alkermes
ALKS
+$19.3M
5
VC icon
Visteon
VC
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 30.67%
2 Industrials 16.05%
3 Consumer Discretionary 13.81%
4 Technology 13.49%
5 Financials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAL icon
201
Delta Air Lines
DAL
$55.9B
$228K 0.01%
8,114
-65
-0.8% -$2.06K
NFLX icon
202
Netflix
NFLX
$292B
$227K 0.01%
+9,640
New +$214K
SPOT icon
203
Spotify
SPOT
$99.2B
$216K 0.01%
2,508
-19
-0.8% -$2.03K
XPO icon
204
XPO
XPO
$25B
$195K 0.01%
7,382
-57
-0.8% -$1.77K
QTWO icon
205
Q2 Holdings
QTWO
$3.42B
$185K 0.01%
5,755
– –
U icon
206
Unity
U
$12.5B
$170K 0.01%
5,342
+3,039
+132% +$125K
EPAM icon
207
EPAM Systems
EPAM
$4.69B
$164K 0.01%
453
-2
-0.4% -$765
ICE icon
208
Intercontinental Exchange
ICE
$82.4B
$152K 0.01%
1,687
+7
+0.4% +$702
MASS icon
209
908 Devices
MASS
$293M
$151K 0.01%
9,152
-311,290
-97% -$6.05M
BBBY
210
Bed Bath & Beyond
BBBY
$473M
$133K 0.01%
5,995
– –
AZTA icon
211
Azenta
AZTA
$1.26B
$129K 0.01%
2,999
-25
-0.8% -$1.49K
CWH icon
212
Camping World
CWH
$363M
$114K 0.01%
4,500
– –
DOCU
213
DocuSign
DOCU
$9.63B
$114K 0.01%
2,125
-16
-0.7% -$1K
ATI icon
214
ATI
ATI
$27B
$78K ﹤0.01%
2,920
-890
-23% -$24.8K
BMRA icon
215
Biomerica
BMRA
$4.9M
$75K ﹤0.01%
2,375
– –
PLUG icon
216
Plug Power
PLUG
$2.92B
$74K ﹤0.01%
3,515
– –
CZNC icon
217
Citizens & Northern Corp
CZNC
$436M
$73K ﹤0.01%
3,000
– –
PXD
218
DELISTED
Pioneer Natural Resource Co.
PXD
$65K ﹤0.01%
300
– –
ENVX icon
219
Enovix
ENVX
$862M
$62K ﹤0.01%
+3,886
New +$57.4K
ZUO
220
DELISTED
Zuora, Inc.
ZUO
$59K ﹤0.01%
8,000
+2,900
+57% +$25K
ARKG icon
221
ARK Genomic Revolution ETF
ARKG
$1.51B
$56K ﹤0.01%
1,696
– –
FLL icon
222
Full House Resorts
FLL
$84.5M
$56K ﹤0.01%
10,000
– –
SDS icon
223
ProShares UltraShort S&P500
SDS
$406M
$55K ﹤0.01%
200
-120
-38% -$27.1K
AQUA
224
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$53K ﹤0.01%
1,600
– –
CSSE
225
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$52K ﹤0.01%
7,500
– –
7 8
9
10 11

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Emerald Advisers held 264 positions worth $1.94B, down 0.32% from $1.94B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q3 2022 filing shows 14 new, 88 increased, 101 reduced and 15 closed positions. Its largest new stake was Blueprint Medicines: 318,574 shares worth $21M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $24.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Emerald Advisers's largest Q3 2022 buy was Blueprint Medicines: 318,574 shares worth $21M.
  • Emerald Advisers added most to AdaptHealth in Q3 2022, an estimated $19.3M increase.
  • Emerald Advisers's biggest Q3 2022 reduction was Avient, cutting an estimated $21.7M.
  • Emerald Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $24.9M.
  • Emerald Advisers's ten largest holdings make up 18% of its $1.94B portfolio in Q3 2022.
  • Emerald Advisers opened 14 new positions and closed 15 in Q3 2022.
  • Emerald Advisers's portfolio value fell 0.32% quarter-over-quarter to $1.94B.

Based on Emerald Advisers's 13F filing for Q3 2022, filed 25 Oct 2022.